Maturation of human cardiac organoids are required for disease modelling and drug discovery
Mark W. Pocock, Janice D. Reid, Harley R. Robinson, Natalie Charitakis, James Robert Krycer, Simon Richard Foster, Rebecca L. Fitzsimmons, Mary Lor, Lynn Devilée, Christopher A. P. Batho, Natasha Tuano, Sara E. Howden, Katerina Vlahos, Kevin I. Watt, Adam T. Piers, , James E. Hudson
This study shows that maturing human cardiac organoids enhances disease modeling and drug discovery by mimicking in vivo development and enabling therapeutic testing for DSP cardiomyopathy.
Nature Cardiovascular Research · Jun 25, 2025Peer-reviewedBioengineering